Portfolio News
Sofinnova Capital
Nucana plc announces pricing of initial public offering
Nucana plc announces pricing of initial public offering
Related News
Elevara Medicines Raises $70 Million Series A to Advance Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline
Mission Therapeutics raises $13.3 million to progress first-in-class Parkinson’s disease candidate MTX325 through clinical trials
Verley becomes first company to receive FDA "No Questions Letter" for functionalized dairy Proteins made via precision fermentation
NanoPhoria Bioscience secures €83.5 Million Series A to advance breakthrough heart failure therapy and expand portfolio for novel Nano-in-Micro delivery platform
AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment of Stargardt Disease